Mon, Sep 26|
FOR RAS Researchers : 4th Annual RAS-Targeted Drug Development Summit
Finally Defeat Resistance to RAS by Supercharging the Development of Best-in-Class & Next Generation Therapies Against All RAS Mutations in Lung, NSCLC, Pancreatic & Other Clinically Unmet RAS-Driven Cancers. Register at https://ras-drugdevelopment.com/
Time & Location
Sep 26, 2022, 10:00 AM EDT – Sep 28, 2022, 10:00 AM EDT
About the Event
The 4th RAS-Targeted Drug Development Summit returns as the definitive industry dedicated forum for the whole community of individuals committed to targeting RAS. Bigger and better than ever before, we will unite 300+ experts to showcase 3-days of exclusive, never shared before data as we delve into accelerating discovery and emerging strategies, optimizing translation and pre-clinical development, and advancing the landscape of clinical trials for combinations and monotherapies.
This year’s forum returns as the only industry-focused event wholly dedicated to RAS-mutant cancers. With this, we will be uniting all experts from across the globe to spend 3 days in Boston, learning, discussing, and progressing anti-RAS therapies to the patient.
For more information, click here.